1 AZITHROMYCIN | 10 of 540 | 3100 prescriptions Less than 1% of all prescriptions | 2240 | 890 patients 24% of all patients | 640 patients 17% of all patients | A |
2 MONTELUKAST SODIUM | 120 of 610 | 2380 prescriptions Less than 1% of all prescriptions | 1410 | 670 patients 18% of all patients | 460 patients 12% of all patients | |
3 ANORO ELLIPTA (UMECLIDINIUM BRM/VILANTEROL TR) | 70 of 590 | 2220 prescriptions Less than 1% of all prescriptions | 1940 | 560 patients 15% of all patients | < 11 | |
4 VENTOLIN HFA (ALBUTEROL SULFATE) | 160 of 700 | 2380 prescriptions Less than 1% of all prescriptions | 1480 | 770 patients 21% of all patients | 490 patients 13% of all patients | |
5 SYMBICORT (BUDESONIDE/FORMOTEROL FUMARATE) | 140 of 650 | 2240 prescriptions Less than 1% of all prescriptions | 1620 | 550 patients 15% of all patients | 380 patients 10% of all patients | |
6 RANITIDINE HCL | 30 of 150 | 1210 prescriptions Less than 1% of all prescriptions | 1020 | 500 patients 14% of all patients | < 11 | |
7 INCRUSE ELLIPTA (UMECLIDINIUM BROMIDE) | 80 of 590 | 2140 prescriptions Less than 1% of all prescriptions | 1570 | 410 patients 11% of all patients | 280 patients 8% of all patients | |
8 THEOPHYLLINE ANHYDROUS | 20 of 130 | 1340 prescriptions Less than 1% of all prescriptions | 820 | 270 patients 7% of all patients | < 11 | |
9 SPIRIVA (TIOTROPIUM BROMIDE) | 40 of 520 | 1310 prescriptions Less than 1% of all prescriptions | 1040 | 270 patients 7% of all patients | < 11 | |
10 TRELEGY ELLIPTA (FLUTICASONE/UMECLIDIN/VILANTER) | 50 of 460 | 1210 prescriptions Less than 1% of all prescriptions | 910 | 410 patients 11% of all patients | 280 patients 8% of all patients | |
11 ADVAIR DISKUS (FLUTICASONE PROPION/SALMETEROL) | 160 of 630 | 1010 prescriptions Less than 1% of all prescriptions | 660 | 320 patients 9% of all patients | 210 patients 6% of all patients | |
12 BREO ELLIPTA (FLUTICASONE/VILANTEROL) | 260 of 630 | 1220 prescriptions Less than 1% of all prescriptions | 850 | 260 patients 7% of all patients | < 11 | |
13 PREDNISONE | 120 of 670 | 2460 prescriptions Less than 1% of all prescriptions | 1560 | 950 patients 26% of all patients | 650 patients 18% of all patients | |
14 SPIRIVA RESPIMAT (TIOTROPIUM BROMIDE) | 30 of 480 | 890 prescriptions Less than 1% of all prescriptions | | 230 patients 6% of all patients | < 11 | |
15 OMEPRAZOLE | 110 of 380 | 570 prescriptions Less than 1% of all prescriptions | 390 | 210 patients 6% of all patients | < 11 | |
16 PROAIR HFA (ALBUTEROL SULFATE) | 90 of 500 | 820 prescriptions Less than 1% of all prescriptions | 630 | 290 patients 8% of all patients | < 11 | |
17 FLUTICASONE PROPIONATE | 200 of 580 | 710 prescriptions Less than 1% of all prescriptions | 510 | 380 patients 10% of all patients | < 11 | |
18 COMBIVENT RESPIMAT (IPRATROPIUM/ALBUTEROL SULFATE) | 100 of 450 | 550 prescriptions Less than 1% of all prescriptions | 390 | 170 patients 5% of all patients | < 11 | |
19 DALIRESP (ROFLUMILAST) | 110 of 380 | 570 prescriptions Less than 1% of all prescriptions | 290 | < 11 | < 11 | |
20 ALPRAZOLAM | 20 of 170 | 700 prescriptions Less than 1% of all prescriptions | 490 | 110 patients 3% of all patients | < 11 | |
21 POTASSIUM CHLORIDE | 70 of 170 | 290 prescriptions Less than 1% of all prescriptions | 290 | < 11 | < 11 | |
22 THEOPHYLLINE (THEOPHYLLINE ANHYDROUS) | 60 of 130 | 320 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
23 STIOLTO RESPIMAT (TIOTROPIUM BR/OLODATEROL HCL) | 60 of 350 | 380 prescriptions Less than 1% of all prescriptions | | 120 patients 3% of all patients | < 11 | |
24 AZELASTINE HCL | 30 of 120 | 300 prescriptions Less than 1% of all prescriptions | | 200 patients 5% of all patients | < 11 | |
25 IPRATROPIUM BROMIDE | 40 of 150 | 310 prescriptions Less than 1% of all prescriptions | | 130 patients 4% of all patients | < 11 | |
26 DULERA (MOMETASONE/FORMOTEROL) | 20 of 100 | 210 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
27 ESBRIET (PIRFENIDONE) | 20 of 180 | 360 prescriptions Less than 1% of all prescriptions | 360 | < 11 | < 11 | |
28 OFEV (NINTEDANIB ESYLATE) | 50 of 250 | 350 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
29 THEO-24 (THEOPHYLLINE ANHYDROUS) | 20 of 50 | 260 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
30 DOXYCYCLINE HYCLATE | 60 of 390 | 760 prescriptions Less than 1% of all prescriptions | 530 | 440 patients 12% of all patients | < 11 | A |
31 CHANTIX (VARENICLINE TARTRATE) | 40 of 90 | 220 prescriptions Less than 1% of all prescriptions | 110 | 120 patients 3% of all patients | < 11 | |
32 BUPROPION HCL SR (BUPROPION HCL) | 30 of 50 | 170 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
33 FUROSEMIDE | 180 of 320 | 170 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
34 ETHAMBUTOL HCL | 100 of 150 | 110 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
35 AMOXICILLIN-CLAVULANATE POTASS (AMOXICILLIN/POTASSIUM CLAV) | 30 of 300 | 660 prescriptions Less than 1% of all prescriptions | 430 | 380 patients 10% of all patients | 270 patients 7% of all patients | A |
36 ADVAIR HFA (FLUTICASONE PROPION/SALMETEROL) | 90 of 150 | 160 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
37 CLONAZEPAM | 140 of 210 | 140 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
38 ELIQUIS (APIXABAN) | 120 of 170 | 140 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
39 PANTOPRAZOLE SODIUM | 220 of 320 | 110 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
40 XOPENEX HFA (LEVALBUTEROL TARTRATE) | 60 of 70 | 110 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
41 KLOR-CON 8 (POTASSIUM CHLORIDE) | 10 | 120 prescriptions Less than 1% of all prescriptions | 120 | < 11 | < 11 | |
42 ZOLPIDEM TARTRATE ER (ZOLPIDEM TARTRATE) | 20 of 20 | 110 prescriptions Less than 1% of all prescriptions | 110 | < 11 | < 11 | |
43 CEFUROXIME (CEFUROXIME AXETIL) | 50 of 70 | 340 prescriptions Less than 1% of all prescriptions | | 240 patients 7% of all patients | < 11 | A |